BioAge Labs Inc. (BIOA) quarterly cash flow statement — complete operating, investing & financing history
BioAge Labs Inc. (BIOA) cash flow statement — 4-year operating, investing & financing cash flows
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q1'23 |
|---|
| Cash from Operations | -30.96M | -19.26M | -24.05M | -28.25M | -16.04M | -19.97M | -17.36M | -5.14M | -14.93M | -15.78M | -15.67M | -8.5M | -10M |
| Operating CF Margin % | -10388.93% | -785.8% | -867.46% | -917.84% | -781.11% | -827.9% | -1196.62% | - | - | - | - | - | - |
| Operating CF Growth % | -92.96% | 3.55% | -38.49% | -449.84% | -7.45% | -26.54% | -10.79% | 39.57% | - | - | - | - | - |
| Net Income | -33.5M | -26.1M | -22.25M | -25.94M | -20.17M | -21.56M | -12.93M | -21.13M | -23.41M | -13.58M | -12.99M | -20.96M | -11.08M |
| Depreciation & Amortization | 80K | 70K | 63K | 69K | 49K | 58K | 37K | 47K | 38K | 49K | 33K | 41K | 33K |
| Stock-Based Compensation | 4.64M | 4.27M | 4.26M | 2.72M | 2.79M | 3.23M | 2.95M | 2.72M | 1.85M | 1.56M | 852K | 767K | 734K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -5.35M | -321K | -118K | -1.36M | 60K | 94K | 111K | -359K | 359K | 130K | 1.14M | 7.12M | 661K |
| Working Capital Changes | 3.17M | 2.82M | -5.99M | -3.74M | 1.23M | -1.79M | -7.53M | 13.58M | 6.23M | -3.94M | -4.7M | 4.53M | -345K |
| Change in Receivables | 60K | 84K | 60K | -254K | 88K | -242K | -361K | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -3.67M | 2.58M | 326K | -2.31M | 3.65M | -2.6M | 2.05M | -126K | 1.34M | -1.57M | 361K | 1.31M | -1.23M |
| Cash from Investing | 7.54M | -164.51M | -46.75M | -14.43M | 12.84M | -15.64M | -77.99M | -26K | -305K | -35K | 0 | 0 | -111K |
| Capital Expenditures | -18K | -328K | -26K | -112K | -22K | -159K | -426K | -26K | -305K | -35K | 0 | 0 | -11K |
| CapEx % of Revenue | 6.04% | 13.38% | 0.94% | 3.64% | 1.07% | 6.59% | 29.36% | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 2.08M | 15.97M | 123.72M | 16.01M | -1.54M | -1.5M | -1.5M | 24.9M | 190.68M | -2.39M | 168M | -1.01M | 23.5M |
| Debt Issued (Net) | 0 | -500K | -1.5M | -1.5M | -1.5M | -1.5M | -1.5M | -1.5M | -1.5M | -1.5M | -1.5M | -1M | 23.5M |
| Equity Issued (Net) | 0 | 17.32M | 126.02M | 17.87M | 0 | 0 | 0 | 27.62M | 542K | -40K | 169.5M | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 98K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 2.08M | -859K | -807K | -356K | -44K | 0 | 0 | -1.22M | 191.64M | -847K | 3K | -9K | -4K |
| Net Change in Cash | -21.3M | -167.81M | 52.89M | -26.68M | -4.76M | -37.16M | -96.86M | 19.88M | 175.39M | -18.22M | 152.35M | -9.58M | 13.37M |
| Free Cash Flow | -30.98M | -19.59M | -24.07M | -28.36M | -16.07M | -20.13M | -17.79M | -5.16M | -15.24M | -15.82M | -15.67M | -8.5M | -10.01M |
| FCF Margin % | -10394.97% | -799.18% | -868.4% | -921.48% | -782.18% | -834.49% | -1225.98% | - | - | - | - | - | - |
| FCF Growth % | -92.81% | 2.68% | -35.32% | -449.24% | -5.45% | -27.26% | -13.51% | 39.27% | - | - | - | - | - |
| FCF per Share | -0.67 | -0.44 | -0.57 | -0.79 | -0.45 | -0.56 | -0.50 | -0.14 | -0.45 | -0.46 | -0.46 | -0.25 | -1.34 |
| FCF Conversion (FCF/Net Income) | 0.92x | 0.74x | 1.08x | 1.09x | 0.80x | 0.93x | 1.34x | 0.24x | 0.64x | 1.16x | 1.21x | 0.41x | 0.90x |
| Interest Paid | 0 | -41K | 41K | 85K | 133K | 176K | 217K | 275K | 335K | 383K | 427K | 468K | 73K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |